首页> 外文会议>Conference on lasers in surgery: Advanced characterization, therapeutics, and systems XI >Improved diagnosis and therapy of superficial transitional cell carcinoma (TCC) of the urinary bladder by 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PPIX) fluorescence: a prospective study in 100 patients
【24h】

Improved diagnosis and therapy of superficial transitional cell carcinoma (TCC) of the urinary bladder by 5-aminolevulinic acid (5-ALA) induced protoporphyrin IX (PPIX) fluorescence: a prospective study in 100 patients

机译:5-氨基乙酰丙酸(5-ALA)诱导的原卟啉IX(PPIX)荧光改善了膀胱浅表移行细胞癌(TCC)的诊断和治疗:一项对100例患者的前瞻性研究

获取原文

摘要

The prognosis of superficial bladder cancer is strongly related to a high recurrence rate and the presence of concomitant,, plane" tumor lesions uch as severe dysplasia or carcinoma in situ. They are frequently overlooked on white light cystoscopy. Furthermore, the traditional transurethral tumor resection of superficial bladder tumor is fredquently incomplete. This prospective study aimed to evaluate whether or not 5-ALA induced PPIX fluores-cence cystoscopy could increase the detection of superficial bladder tumors and/or ,, plane" carcinoma in situ invisible on white light cystoscopy. 100 patients with superficial TCC of the urinary bladder underwent cystoscopy under white light and under blue fluorescence light. 2 hours (1-4 hours) prior to cystoscopy 50 ml 3 per cent 5-ALA-solution were intravesically instilled into the empty bladder. All lesions visible on white light cystoscopy were compared with fluorescence findings and, vice versa, all fluorescence findings werde compared with white light cystoscopy findings. All lesions visible under white light, and all lesions only visible under 5-ALA induced fluorescence were resected/biopsied and histologically examined. A total 515 resections/biopsies was performed (5. 15 biopsies per patient). 297 tumors were detected, 257 of 297 (86.5 per cent) on white light, and 288 of 297 (96.7 per cent) on fluorescence cystoscopy. 9 of 297 tumors (3.0 per cent) were only detected by white light, but 31 of 297 tumors (10.4 per cent) were only detected by fluorescence cystoscopy, i.e. the mucosa was looking normal under white light but showed positive fluorescence; 7/77 (9.0 percent) pTaG1, 13/96 (13.5 per cent) pTaG2, 3/48 (6.3 per cent) pT1G2, 15/43 (34.9 per cent) pTaG3 or Cis and 2/23 (8.7 per cent) pT1G3 tumors. A total of 17 of 66 grade 3 superficial TCC would have been overlooked on white light cystoscopy, a finding of clinical importance. The sensitivity and specificity of white light cystos copy was 86.5 per cent and 45.4 per cent, respectively, wheras the sensitivity and specificity of fluorescence cystoscopy was 96.7 per cent and 26.6 per cent, respectively. No local or systemic side effects of intravesical instillation of 5-ALA solution was observed. In conclusion, ALA-induced fluorescence endoscopy proved to be a safe method to increase the tumor detection rate, especially the detection of carcinoma in situ and highly malignant pT1G3 tumors.
机译:浅表性膀胱癌的预后与高复发率以及伴随的,平面的“肿瘤”病变(如严重的不典型增生或原位癌)密切相关。在白光膀胱镜检查中经常被忽视。此外,传统的经尿道肿瘤切除术这项前瞻性研究旨在评估5-ALA诱导的PPIX荧光膀胱镜检查是否可以增加对浅表膀胱肿瘤和/或在白光膀胱镜检查中不可见的平面“原位癌”的检测。 100例膀胱浅表TCC患者在白光和蓝色荧光下进行了膀胱镜检查。膀胱镜检查前2小时(1-4小时)将50 ml 3%的5-ALA溶液膀胱内滴注到空的膀胱中。将在白光膀胱镜检查中可见的所有病变与荧光检查结果进行比较,反之亦然,将所有荧光检查结果与白光膀胱镜检查结果进行比较。切除/活组织检查并在白光下可见的所有病变和仅在5-ALA诱导的荧光下可见的所有病变。总共进行了515次切除/活检(每位患者5. 15次活检)。在白光下检测到297个肿瘤,在297个肿瘤中检测到257个(86.5%),在荧光膀胱镜检查中检测到297个肿瘤中的288个(96.7%)。 297个肿瘤中有9个(3.0%)仅通过白光检测到,而297个肿瘤中有31个(10.4%)仅通过荧光膀胱镜检查被检测到,即粘膜在白光下看起来正常,但显示阳性荧光; 7/77(9.0%)pTaG1、13 / 96(13.5%)pTaG2、3 / 48(6.3%)pT1G2、15 / 43(34.9%)pTaG3或Cis和2/23(8.7%)pT1G3肿瘤。在白光膀胱镜检查中,总共有66个3级浅表TCC中有17个会被忽略,这在临床上具有重要意义。白光膀胱镜检查的敏感性和特异性分别为86.5%和45.4%,而荧光膀胱镜检查的敏感性和特异性分别为96.7%和26.6%。没有观察到5-ALA溶液膀胱内滴注的局部或全身性副作用。总之,ALA诱导的荧光内窥镜检查被证明是提高肿瘤检出率的一种安全方法,特别是对原位癌和高度恶性的pT1G3肿瘤的检出。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号